Home
Prothrombin Time International Normalized Ratio (INR)
Monitoring
Date of Revision: 7/5/02 Description
Warfarin
is the oral anticoagulant most frequently used to
control and prevent thromboembolic disorders.
The goal of anticoagulant therapy is to
administer the lowest possible dose of anticoagulant to
prevent clot formation or expansion. The required degree of anticoagulation continues to evolve as
studies provide more information about the efficacy and
safety of lower doses. The
prothrombin time (PT) is the primary assay used in
monitoring warfarin therapy.
The standardized use of the International
Normalized Ratio (INR) allows physicians to determine
the level of anticoagulation in a patient independent of
the laboratory reagents used.
The INR is the ratio of the patient’s
population time compared to the mean prothrombin time
for a group of normal individuals.
The current therapeutic INR goal for patients
with mechanical prosthetic heart valves is 2.5-3.5. The
monitoring of patient’s INR level to maintain patients
within the therapeutic range is accomplished in a
physician’s office, anticoagulant clinics, or home
monitoring. Patient
self-testing and self-management through the use of a
home INR monitor may be used to improve the time in
therapeutic rate for a select group of patients.
This policy addresses coverage of home monitoring
of INR levels. Indications and Limitations of Coverage and/or Medical Necessity Effective
for services performed on or after July 1, 2002,
carriers will cover the use of home prothrombin time INR
monitoring for anticoagulation management for patients
with mechanical heart valves on warfarin. The monitor and the home testing must be prescribed by a
physician and the following patient requirements must be
met:
NOTE:
Porcine valves are not covered so Medicare will
not make payment on home INR monitoring for patients
with porcine valves. CPT/HCPCS
Codes
ICD-9
Codes that Support Medical Necessity
Reasons
for Denials When
performed for indications other than those listed in the
"Indications and Limitations of Coverage and/or
Medical Necessity" section of this policy. Noncovered
ICD-9 Codes Any
diagnosis codes not listed in the "ICD-9 Codes That
Support Medical Necessity" section of this policy. Coding
Guidelines
The
cost of the device and supplies are included in the
payment for G0249, therefore, are not separately
billable to the carriers. Documentation
Requirements
Medical
record documentation maintained in the patient’s file
must support that the coverage requirements are met.
In addition, the documentation must support that
the procedure was performed.
This information is normally found in the
office/progress notes, hospital records, and test
results. Utilization
Guidelines HCPCS
code G0250 is per 4 tests, therefore, this code should
only be billed no more than once every 4 weeks.
|
WWW.ACCUCHECKER.COM, LLC Developers of the AccuChecker Product Line The WWW.ACCUCHECKER.COM, LLC marks. |